To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
David Frayman, London School of Economics and Political Science,Christian Krekel, London School of Economics and Political Science,Richard Layard, London School of Economics and Political Science,Sara MacLennan, London School of Economics and Political Science,Isaac Parkes, London School of Economics and Political Science
Mental illness is common: at least 20 per cent of adults suffer from it at any one time. Depression and anxiety disorders are the most common conditions and they reduce life satisfaction by 0.7 points (out of 10). In the UK the health watchdog NICE recommends that all patients are offered psychological therapy. Until 2008 almost none were, but since then, NHS Talking Therapies (NHSTT) has treated some eight million patients of whom half have recovered during therapy. Many have gone back to work and the service brings more money into the Exchequer in taxes paid (and benefits not paid) to more than cover the original cost of the therapy. This happens within two years of the end of treatment. There are also important reductions in the use of NHS physical healthcare services.
But the service does not cover people suffering from addiction, personality disorder or other severe mental illness. This chapter evaluates provision of psychological therapy on a large scale to those people. It concludes that this provision too would pay for itself within two years.
This chapter introduces addiction as a complex, brain-based disorder characterized by compulsive substance use despite negative consequences. It distinguishes the clinical diagnosis of substance use disorder from broader neuroscientific and behavioral conceptualizations of addiction, emphasizing dimensional severity, heterogeneity, and developmental risk. Epidemiological trends, societal burden, and the role of stigma are discussed to frame addiction as a major public health challenge. The chapter establishes addiction as a disorder of brain circuits involved in reward, motivation, stress, and self-control, setting the foundation for the neurobiological mechanisms explored throughout the book.
This study investigated the architecture and neural activity of white matter functional networks (WMFNs) in individuals with opioid use disorder (OUD) after prolonged abstinence, compared with healthy controls (HCs).
Methods
Blood oxygen level-dependent signals in white matter were analyzed using a data-driven k-means clustering approach across individuals with OUD at baseline (OUD1), the same individuals after prolonged abstinence at follow-up (OUD2), and HCs.
Results
In OUD1, the deep frontoparietal network was fragmented into the superior longitudinal fasciculus network and anterior corona radiata network; this organization partially recovered in OUD2, becoming more similar to HCs. OUD1 also showed hyperactivation in the deep frontal network and hypoactivation in the frontotemporal-parietal network, with frontotemporal-parietal activity negatively correlated with years of opioid use.
Conclusions
OUD is associated with disrupted architecture of WMFNs and altered neural activity, whereas prolonged abstinence may promote partial network restoration. These findings highlight the neuroplastic potential of WMFNs during recovery and provide insights into the neural mechanisms underlying OUD and abstinence-related rehabilitation.
Methamphetamine is a highly addictive psychostimulant associated with widespread neurobiological alterations. While the acute and chronic effects on the brain have been extensively studied in animal models, far less is known about its impact on the human brain, particularly in the context of inhibitory processing.
Methods
Seventy-two participants (35 who regularly use methamphetamine) completed a paired-pulse somatosensory gating paradigm during magnetoencephalography (MEG). Immediately before the first stimulation of each trial, participants viewed either a substance-related or neutral image. The resulting responses were imaged, and time series were extracted from the peak voxel in the whole-brain maps, which was centered on the contralateral postcentral gyrus. Gating ratios (Stimulation 2/Stimulation 1) were subjected to a linear mixed-effect model, and spontaneous activity in the same voxel was assessed.
Results
We found a significant group-by-condition interaction and a main effect of group, with the latter indicating that controls had significantly stronger gating across both task conditions compared to the methamphetamine group. Interestingly, the interaction revealed that only those in the methamphetamine group exhibited weaker gating in the substance-cue compared to the neutral image condition. Furthermore, gating indices were predictive of processing speed above and beyond the effect of group, while spontaneous gamma during the baseline was elevated in the methamphetamine group compared to controls.
Conclusions
Adults who use methamphetamine exhibit altered gating responses and elevated spontaneous gamma activity in the somatosensory cortices, likely reflecting disruptions in GABAergic circuitry. Substance-related cues accentuated gating deficits, suggesting that cue reactivity may compromise sensory inhibition in this population.
Gambling disorder frequently co-occurs with other psychiatric conditions, yet its relationship with obsessive-compulsive disorder (OCD) remains unclear. Emerging evidence suggests impulsivity and compulsivity may be inter-related rather than diametrically opposed constructs, warranting investigation of their clinical overlap. The aim of this study is to examine the rate of gambling disorder in adults with OCD and to explore associated clinical, behavioral, and treatment-related characteristics.
Methods
Adults with probable OCD were recruited via online Reddit groups for OCD, OCD clinics, and support groups and completed a cross-sectional survey. OCD symptom types were assessed using the Obsessive-Compulsive Inventory-Revised, and gambling disorder was identified using the Minnesota Impulsive Disorders Interview. Additional measures included gambling severity, impulsivity, and problematic internet use. Group comparisons were conducted between participants with and without gambling disorder.
Results
Among 186 adults with OCD, 34 (18.8%) met criteria for gambling disorder. Individuals with comorbid gambling disorder demonstrated significantly greater OCD severity, particularly in ordering, checking, and neutralizing symptoms, and reported later onset of OCD. The comorbid group showed higher impulsivity, greater problematic internet use, and distinct gambling behaviors, including higher rates of online gambling, esports betting, and use of artificial intelligence tools for gambling. They were also less likely to have received pharmacological treatment for OCD.
Conclusions
Gambling disorder in adults with OCD is associated with distinct clinical characteristics, greater impulsivity, problematic internet use, and concerning treatment gaps. These findings highlight the importance of screening for gambling in OCD, and vice versa, and suggest a need for integrated treatment approaches.
To identify and characterise active national illicit drug use sentinel surveillance systems worldwide.
Methods:
We conducted a scoping review to identify and characterise active sentinel surveillance systems for illicit drug use worldwide. Inclusion criteria: 1) articles describing or analysing data from sentinel networks with an established national scope, 2) supported by public agencies, and 3) data accessible via online repositories. We excluded articles on networks which did not have drug surveillance as their main designated objective.
Results:
Ten sentinel surveillance systems targeting recreational drug use at the national level were identified. Even though each has its own structure and functionality, they are often integrated in larger surveillance programmes. Although health professionals in emergency departments are the main informants, some systems also include information directly from people who use drugs or from community stakeholders. Systems also varied in their operational characteristics, including reporting frequency and methods used to disseminate findings.
Conclusion:
Having similarities, awareness of these different characteristics makes it possible to improve the design of surveillance systems directed towards illicit drug use monitoring and surveillance.
Affect makes us vulnerable to attention capture. William Burroughs explored the aesthetic functions of playing with and capturing attention through his comic routines, his writing and his performances. This chapter shows how the outrageousness of Burroughs’ routines and his iconic performances in “Chappaqua,” “Drugstore Cowboy” and “The Black Rider” break down defensiveness through laughter and expose the enablers and drivers of addiction, challenging us to rethink our vulnerabilities in the face of drugs, social institutions, and new forms of media. His comic routines and performances reveal the social drivers of addiction, such as the health system’s involvement in the opioid crisis and the War on Drugs’ investment in social control, and anticipate the capture and resale of attention leading to the contemporary “attention economy,” the profits of surveillance capitalism and engineered addiction to social media.
Burroughs’ writing is widely interpreted to depict existence in terms of universal addiction, and a fight against it. This chapter shows the extent to which drug use in his life and work lies outside this simplistic model. His ‘Algebra of Need’ polemics are shown to belong to a specific period, and an account of his career with drugs outlines his opiate use; his excursion into hallucinogens, notably yagé, as psychic exploration; and his chosen literary precursors, notably De Quincey. Burroughs became more comfortable with his dependency in later life, and he finally emphasizes drug use, particularly in an American historical context, as a libertarian political issue. The chapter notes his depiction of drug experience as a potentially valuable subjective space, together with nostalgia and dreaming, and suggests that a common denominator throughout his changing stances on drugs is freedom: not only from addiction, but from the body, and from social control.
The foundation of the chapter is the distinction between regulation and control, and the link between them. The distinction is exemplified by the regulation of body temperature by means of control actions;for example, shivering, sweating, and changing the relation with the environment. The latter reflects motivation. The discussion then goes on to document a number of phenomena that also illustrate regulation and control: non-suicidal self-injury, hair pulling, skin picking, addictions of various sorts, and borderline personality disorder.
Chemsex is a pattern of using specific drugs with the intent of enhancing the sexual experiences of men who have sex with men. Chemsex participation is often motivated by a desire for community connection or enhanced sexual pleasure. Many individuals who participate in chemsex can mitigate much of the associated risk and report limited, if any, harm. However, for some, chemsex can be problematic, precipitating or exacerbating mental health issues. Despite increasing amounts of research into chemsex, there is no consensus about how to best support people who participate in chemsex when they present for psychological therapies. In the absence of specific clinical guidelines, this paper explores the intersection of chemsex and mental health problems. Principles of affirming and non-stigmatising, assessment, formulation, and intervention strategies are discussed, and recommendations are made throughout. Drawing on contemporary evidence, we present cognitive behavioural approaches to supporting service users who participate in chemsex with anxiety, depression, and post-traumatic stress disorder. By enhancing cultural safety and tailoring existing evidence-based treatments, therapists can improve engagement and outcomes for individuals who engage in chemsex. We recommend an inclusive approach that champions service user choice, paired with a sensitive, sex-positive, and trauma-informed perspective. Therapists within Talking Therapy services are well placed to support service users who participate in chemsex and have co-occurring mental health difficulties.
Key learning aims
(1) To understand what chemsex is, what motivates chemsex participation, and the distribution of potential risks.
(2) To understand the intersection of sexuality, chemsex, and co-occurring mental health difficulties, including the role of pleasure, identity, shame and community.
(3) To identify the key barriers experienced by people who participate in chemsex when accessing mental health services, such as negative staff attitudes or fear of stigma.
(4) To explore cognitive behavioural approaches to working with people who participate in chemsex, and associated common mental health difficulties (anxiety, depression, and post-traumatic stress disorder).
(5) To identify practical strategies to engage service users who participate in chemsex.
The neo-Brandeisian anti-monopoly movement that emerged in the United States following the 2008 financial crisis provides a new perspective on anti-monopoly thought, politics, and practice in the less recent past. The “home protection” crusade led by renowned temperance activist Frances Willard is a case in point. To combat addiction, domestic violence, and child abuse, Willard joined like-minded temperance activists in the 1870s to form the Woman’s Christian Temperance Union, a grassroots women-led social movement to ban the “liquor traffic.” To free the nation from its “monopoly in sin,” Willard opposed federal alcohol taxes and municipal liquor-retailing licensing fees. Inspired by the utopian journalist Edward Bellamy and the Fabian socialists Sidney and Beatrice Webb, Willard reinvented herself in the 1890s as a Christian socialist committed to improving the living conditions of the poor—an anti-monopoly ideal more expansive than anything championed by the lawmakers who drafted the 1890 law known today as the Sherman Act.
The control of alcohol and other drugs (AOD) is an important feature of the global public policy landscape. There is widespread recognition that the ‘war on drugs’, rooted in international systems of drug control, has failed both on its own terms and because of the harms it has visited upon users and their communities. Although some states have moved towards liberalisation, the vast majority continue to heavily invest in punitive measures. Importantly, however, key ideas about drugs are coming under sustained pressure, and in some instances, beginning to break down, including the idea that drugs inevitably produce harms, including illness, injury and death, or that they produce other predictable, stable and consistent ‘effects’ (Fraser and Moore, 2011). There is evidence of this change in specific contexts including drug policy, health promotion and service provision. But what is happening in law courts? How are drugs being conceptualised in legal cases around the world? Scholars from a variety of disciplines have taken a keen interest in the ‘drug problem’, but there has been little scrutiny of how key cases in different jurisdictions have influenced the ways in which we understand, respond to and punish the use of various substances. The importance of such decisions extends beyond criminal matters and affects outcomes in a variety of legal spheres including immigration, welfare, family justice, education and employment law. Judging Drugs is the first book to chart the impact and significance of those cases in different parts of the world, and to consider how ideas about drugs are (or might be) changing across our courts. It thus comprises an important and distinctive addition to a body of scholarship that has sought to understand the ways in which drugs and ‘addiction’ have been subject to varying degrees of control and opprobrium. Importantly, contributors to this edited collection do not simply identify and summarise important legal cases from around the world. In this sense, the collection is not a ‘textbook’ of important case law. It is also not a textbook of cases with apparent precedent value.
Methadone maintenance therapy arose as a treatment for opiate use in the mid 1960s. At the time, neither drug use nor treatment for it were considered disabilities. When Vincent Dole, the Rockefeller Institute metabolic researcher who was one of the progenitors of methadone maintenance therapy (MMT), asked, ‘What kind of disablement does a drug produce?’ (Courtwright et al., 1989, p. 334), this was a prescient question.1 Dole’s team stabilised patient-subjects on methadone, hoping to displace reliance on shorter-acting opiates, and explored dosages that would enable ‘cooperative relationships with patients’ (Courtwright, et al., 1989, p. 336). Opposing detoxification and abstinence as the sole basis for treatment, Dole saw opioid use disorder as a metabolic condition that required ongoing pharmacological stability. Contrasting the stabilising effects of one opiate (methadone) to another (heroin), Dole emphasised that drugs should be judged in terms of their social effects – did they improve or undermine capacity for stable relationships with family members, treatment providers or employers? Did they produce ‘disablement’ or did they instead ‘enable’ capacities for productive citizenship? Such questions dominated the social contexts into which methadone maintenance was inserted. Making stable, productive citizens was adopted as the goal of methadone maintenance.
Supervised consumption sites (SCS) are spaces where people can use pre-acquired drugs under the supervision of trained staff who monitor for overdose and administer medical assistance, if necessary.1 By providing sterile drug use supplies, referrals to various services and education about safer injection practices, SCS function as harm reduction apparatuses for reducing overdose and the transmission of blood-borne infections like human immunodeficiency virus (HIV) and hepatitis C (HCV) and other harms associated with drug use such as skin and soft tissue infections.2 While at least one unsanctioned SCS exists in the United States (Kral & Davidson, 2017), there are currently only three government-authorised sites in the country; two opened in 2021 in New York City and one opened in 2024 in Rhode Island. Another SCS was poised to open years earlier in Philadelphia, Pennsylvania, until the US federal government sued Safehouse, the organisation set to manage the site, to prevent it from opening. The government argued that Safehouse would violate federal law if it opened an SCS because the US Controlled Substances Act (CSA) (1970) prohibits the operation of places where drugs are made or used illicitly.
The day after launching a full-scale invasion of Ukraine in 2022, in a public speech addressed to multiple audiences, Putin called for the ‘overthrow’ of the Ukrainian government, which he labelled a ‘gang of narcomany (‘drug addicts’) and neo-Nazis’ (Roth, 2022). We will return to the significance of this speech later; here we would add to the picture that after Russia’s initial invasion of Ukraine in 2014, in all territories under Russian occupation, opioid agonist therapy (OAT) programmes were immediately shut down, reflecting their status as being also banned in Russia.
This chapter provides multiple-choice questions designed to reinforce and expand your knowledge of substance use disorders and impulsive-compulsive disorders, including neurobiology of impulsivity and compulsivity, neurobiology of reward, mechanisms of drugs of abuse, treatments for substance use disorders, and treatments for impulsive-compulsive disorders such as obsessive compulsive disorder (OCD).
This case report presents the case of a 25-year-old woman who developed ketamine addiction following a single sub-anaesthetic dose of intranasal ketamine in a pilot study investigating intranasal racemic ketamine for acute suicidality. She had a history of depression, obsessive–compulsive disorder, autism spectrum disorder and anorexia nervosa, and she had sporadically used alcohol and cannabis. Following the intervention, she reported a transient reduction in suicidal ideation but later sought illicit ketamine to recreate its calming effects on intrusive thoughts. Subsequently she also started abusing cocaine and 3-methylmethcathinone (3-MMC). Within weeks she had escalated to daily use, which led to financial distress, housing instability and a suicide attempt when access was cut off. Although she initially ceased use, she later relapsed into ketamine and cocaine addiction. This case highlights the addictive risk of ketamine, even in controlled settings. Given ketamine’s rising use in psychiatric treatment, careful screening, monitoring and awareness of addiction potential are essential. Future research should evaluate patient-specific risk factors and dosing strategies to minimise abuse liability.
Methamphetamine use disorder (MUD) has risen among women globally and is disproportionately higher in prisons. In Indonesia, correctional facilities still lack any structured and evidence-based psychological therapy. To address this gap, we developed the Indonesia Substance Use Reduction for Female Therapy (Indo-SURFT).
Methods:
A single-arm unblinded design with a 3-month follow-up was conducted among incarcerated women with MUD. Participants completed 12 sessions over six weeks. Assessments included user perception ratings, Addiction Severity Index (ASI), Visual Analog Scale for craving, University of Rhode Island Change Assessment Scale, Self-Reporting Questionnaire-20 (SRQ-20), and WHO Quality-of-Life Brief (WHOQOL-BREF).
Results:
A total of 33 incarcerated women with MUD participated and the median age was 35 (21–57). All of the participants had complete attendance during the 6-week program. By week 12, participants rated the Indo-SURFT module as useful (Mdiff = 0.484, 95%CI [0.235, 0.732], p < 0.001, d = 0.482). Employment-related ASI scores improved post-intervention (B = −0.076, p = 0.002) and at follow-up (B = −0.106, p = 0.004). Psychiatric domain of ASI remained stable post-intervention but increased after follow-up (B = 0.200, p ≤ 0.001). Craving declined post-treatment but rose at follow-up (B = 1.247, p = 0.036). SRQ-20 increased over time, while WHOQOL-BREF declined.
Conclusions:
Indo-SURFT is tolerable and feasible for women with MUD in incarceration. Participants highly rated the module and delivery. The module demonstrates initial improvement in functional domain and curbs craving level during treatment. Maintenance sessions may be required to fully maintain and enhance improvements. These findings support Indo-SURFT’s as a potential intervention but requires further multisite investigation to enhance generalizability.
Every day, judges determine vital questions about 'addiction', 'drugs', and the rights of those who use them. Despite the law's crucial role in handling drug 'problems', and in shaping drug practices, effects and outcomes, drug scholars have often overlooked case law. In a rapidly changing drug policy landscape, how is the law managing drug effects and harms, stigma, addiction, agency and responsibility? Why do we regulate drugs? Are drug offenders responsible for their actions? Is drug use a disability? Is drug treatment a human right? Do drugs cause harm? And might drug law itself be harmful? Authors in this volume take a variety of approaches to these questions and more. Drawing on critical theory, all consider new ways of thinking about 'drug problems'. This vital new collection enables a deeper, critical understanding of how the law 'works' to shape knowledge about, as well as 'judge', drug use and its effects.
Sexual minority (lesbian, gay, bisexual, queer and other non-heterosexual) people experience significant disparities in addiction problems compared with heterosexual people.
Aims
We aimed to answer the question, what are the barriers and facilitators to accessing drug/alcohol addiction treatment services for sexual minority adults?’.
Method
A systematic review was conducted by searching Medline, PsycINFO, CINAHL, Web of Science, and Sociological Abstracts for any English-language primary research article (qualitative, quantitative or mixed methods) relevant to the study aims, from inception up to 18 April 2025. Quality of included studies was assessed using the Mixed-Methods Appraisal Tool (MMAT-2018). Barriers and facilitators were categorised into ‘service-related’ and ‘patient-related’ dimensions of accessibility, and synthesised narratively.
Results
We screened 3282 abstracts, with full-text review of 238 articles; 62 studies met the inclusion criteria. Common service-related barriers included explicit harassment, discrimination, violence or abuse toward sexual minority people in services and lack of expertise or ‘culturally competent’ provision for their specific addiction problems. Facilitators included affirming, non-judgemental staff attitudes and sexual minority-specific treatment or outreach services. Patient-related barriers included ambivalence around drug/alcohol use and a fear of stigma (e.g. around sexualised drug use). Facilitators included signposting to services via community networks or peer advocates, and allowing patients to set their own treatment goals.
Conclusions
Although barriers and facilitators vary across global contexts and time periods, both qualitative and quantitative research highlighted similar key issues. Implementing practical changes to address these may improve sexual minority people’s access to addiction services, reducing the burden of addiction-related health inequity for this community.